Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 02, 2022

BUY
$135.27 - $180.11 $27,054 - $36,022
200 Added 6.67%
3,200 $438,000
Q2 2022

Oct 03, 2022

BUY
$108.81 - $179.33 $73,446 - $121,047
675 Added 29.03%
3,000 $531,000
Q1 2022

Jun 08, 2022

BUY
$119.61 - $157.85 $278,093 - $367,001
2,325 New
2,325 $335,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track American Trust Portfolio

Follow American Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

News

Stay updated on American Trust with notifications on news.